Get In Touch
+123 456 7890
+123 456 7890
info@pharmapoly.com
236 Gray’s Inn Rd, London WC1X 8HB, United Kingdom
Frequently Asked Question!
Synedica markets a range of peptide and other compound products in pen-style kits. The formulation and contents vary depending on the specific product.
The advertised range includes semaglutide, tirzepatide, retatrutide, BPC-157 and TB-500 combinations, HGH, NAD+ and other formulations. Availability and product specifications should be independently verified.
Do not assume that a Synedica-branded product is an approved medicine. Check its regulatory status in the country where it is being supplied.
Some Synedica product information explicitly describes its products as research-use-only and not intended for human consumption or medical treatment. They should not be presented as approved medicines for self-injection.
Check the manufacturer’s official verification process, packaging, batch number and supporting documentation. A verification code alone does not establish safety, sterility or regulatory approval.
Documentation may include batch information, product identity, analytical testing and a Certificate of Analysis. Ask for independently verifiable documentation before relying on quality claims.